GovChime

Rapid Screening of MCM Efficacy Against SARS-CoV-2 Pseudoviruses with Spike Variants

Overview

Response deadline
3:00 PM UTC−04:00
Posted
April 28, 2021
Notice type
Combined Synopsis/Solicitation
NAICS
621511: Medical Laboratories
Agency
Department of Health and Human ServicesOFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE

Notice details

Office
ASPR BARDA DIV CONTRACTS MGMT & ACQ
Last updated
Sep 25, 2026

Identifiers

Solicitation number
75A50121R00033
Notice ID
eab11587a2b0485e861783f7ddfc754b

Description

This is a re-issuance of a solicitation. The small business set-aside is disolved in accordance with FAR 19.502-10 Automatic dissolution of a small business set-aside. See attached CSS with Attachments.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Contracting Officer

Primary Contact

Documents

No documents available.

Lifecycle

Solicitation:75A50121R00033
  1. Combined Synopsis
  1. 2×
    Combined SynopsisCurrentApr 6, 2021

    Rapid Screening of MCM Efficacy Against SARS-CoV-2 Pseudoviruses with Spike Variants

    Notice eab11587a2b0485e861783f7ddfc754b on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

75A50121R00033

Archive Date

May 22, 2021

Office Address

Washington, DC, 20515